MANETTI, MIRKO
 Distribuzione geografica
Continente #
NA - Nord America 14.177
EU - Europa 8.795
AS - Asia 6.512
SA - Sud America 1.277
AF - Africa 222
OC - Oceania 172
Continente sconosciuto - Info sul continente non disponibili 6
Totale 31.161
Nazione #
US - Stati Uniti d'America 14.033
RU - Federazione Russa 3.550
SG - Singapore 1.794
PL - Polonia 1.676
CN - Cina 1.643
HK - Hong Kong 1.121
BR - Brasile 1.038
IE - Irlanda 856
IT - Italia 831
KR - Corea 757
SE - Svezia 651
VN - Vietnam 430
DE - Germania 284
FI - Finlandia 279
IN - India 255
AU - Australia 170
FR - Francia 167
GB - Regno Unito 159
ID - Indonesia 113
JO - Giordania 97
AR - Argentina 90
UA - Ucraina 78
CA - Canada 77
CI - Costa d'Avorio 63
MX - Messico 52
ES - Italia 51
NL - Olanda 49
TR - Turchia 49
BD - Bangladesh 48
IQ - Iraq 42
EC - Ecuador 40
MA - Marocco 37
CH - Svizzera 36
ZA - Sudafrica 35
JP - Giappone 32
CO - Colombia 28
BE - Belgio 23
PH - Filippine 21
PK - Pakistan 20
PY - Paraguay 18
VE - Venezuela 18
LT - Lituania 17
UY - Uruguay 14
AT - Austria 13
BJ - Benin 13
CL - Cile 13
EG - Egitto 13
PE - Perù 13
TN - Tunisia 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
KE - Kenya 11
SA - Arabia Saudita 11
UG - Uganda 11
DK - Danimarca 9
MK - Macedonia 9
LV - Lettonia 8
NP - Nepal 8
SC - Seychelles 8
CZ - Repubblica Ceca 6
RO - Romania 6
GR - Grecia 5
KZ - Kazakistan 5
NO - Norvegia 5
DZ - Algeria 4
EU - Europa 4
IR - Iran 4
JM - Giamaica 4
KG - Kirghizistan 4
LU - Lussemburgo 4
MD - Moldavia 4
TH - Thailandia 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CG - Congo 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IL - Israele 3
ML - Mali 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
GT - Guatemala 2
GY - Guiana 2
LB - Libano 2
LK - Sri Lanka 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CV - Capo Verde 1
Totale 31.149
Città #
Santa Clara 3.094
Warsaw 1.669
Fairfield 1.508
Ashburn 1.362
Singapore 1.272
Hong Kong 935
Dublin 842
Seoul 753
Chandler 732
Woodbridge 685
Seattle 609
Cambridge 604
Houston 569
Hefei 505
Wilmington 460
Beijing 370
Ann Arbor 226
Florence 225
Princeton 222
Lawrence 213
Altamura 206
Los Angeles 204
Buffalo 165
Moscow 156
Melbourne 146
Dallas 144
Ho Chi Minh City 144
Mumbai 142
Medford 138
Munich 136
Paris 121
Boston 118
Jacksonville 118
Boardman 110
São Paulo 100
New York 97
San Diego 89
Hanoi 86
Jakarta 82
Kent 73
Shanghai 72
Helsinki 66
Abidjan 63
Clifton 61
Redondo Beach 58
The Dalles 54
Falls Church 51
Turku 47
Chicago 41
Dong Ket 40
London 40
Norwalk 40
Rio de Janeiro 35
Lappeenranta 32
Milan 30
Toronto 30
Hillsboro 29
Phoenix 29
Guangzhou 28
Brooklyn 25
Barcelona 24
Chennai 24
Bengaluru 23
Johannesburg 23
Montreal 23
Tokyo 23
Yubileyny 23
Andover 22
Belo Horizonte 21
Pune 21
Baghdad 20
Casablanca 20
Izmir 20
Bern 19
Fiesole 19
Rome 19
Perth 18
West Jordan 18
Porto Alegre 17
Atlanta 16
Castelliri 16
Brasília 15
Brussels 15
Frankfurt am Main 15
Orem 15
Stockholm 15
Tianjin 15
Dearborn 14
Denver 14
Haiphong 14
Mexico City 14
Cotonou 13
Falkenstein 13
Nanjing 13
Redwood City 13
Thái Bình 13
Ankara 12
Biên Hòa 12
Campinas 12
Curitiba 12
Totale 20.989
Nome #
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 326
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 304
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 301
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications 273
Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes 266
The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem? 263
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide 257
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 246
Multimodal imaging in the diagnosis and evaluation of intestinal malrotations in adults: a case report 245
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A 222
Psychological well-being and quality of life in visually impaired baseball players: An Italian national survey 221
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 218
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 217
Longitudinal assessment of the impact of adapted physical activity on upper limb disability and quality of life in breast cancer survivors from an Italian cohort 217
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 206
A case of in vivo iontophoresis-assisted corneal collagen cross-linking for keratoconus: An immunohistochemical study 205
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 200
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 200
Role of a Structured Physical Activity Pathway in Improving Functional Disability, Pain and Quality of Life in a Case of Breast and Gynecological Cancer Survivorship 196
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 189
Self-reported active lifestyle behavior and upper limb disability in breast cancer survivors following a structured adapted physical activity intervention 186
A case of mandible hypoplasia treated with autologous bone graft from mandibular symphysis: Expression of VEGF and receptors in bone regeneration. 184
Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice 183
Telocytes in normal and keratoconic human cornea: an immunohistochemical and transmission electron microscopy study 181
TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A 180
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 179
Pathophysiology of Hemophilic Arthropathy 176
Long-Term Benefits of Adapted Physical Activity on Upper Limb Performance and Quality of Life in Breast Cancer Survivors 175
Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. 175
Cardiac Telocyte-Derived Exosomes and Their Possible Implications in Cardiovascular Pathophysiology 173
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 172
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 172
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 169
A two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells 169
Visually impaired dancers vs other sound input-based sport athletes: survey on psychological well-being and quality of life 168
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 167
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis 164
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 164
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 162
XIII National Congress SISMES - Feasibility and efficacy of an adapted physical activity protocol during COVID-19 pandemic: lower limb functional and strength recovery in a young athlete affected by cutaneous melanoma 160
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 160
Targeting anticoagulant protein S to improve hemostasis in hemophilia 159
Concomitant Spondyloarthritis and Tenosynovial Giant Cell Tumor in Pigmented Villonodular Synovitis Challenging Cases 159
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 158
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 158
Reappraising the microscopic anatomy of human testis: identification of telocyte networks in the peritubular and intertubular stromal space 157
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 156
Morphological evidence for telocytes as stromal cells supporting satellite cell activation in eccentric contraction-induced skeletal muscle injury 155
Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome 155
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 155
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study 155
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 154
Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales? 154
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report 153
Effects of a specific adapted upper limb exercise on lymphedema in breast cancer survivors: a pilot study 153
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 152
Stiff skin syndrome: evidence for an inflammation-independent fibrosis? 152
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 151
Blocking Protein S Improves Hemostasis in Hemophilia A and B 151
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 149
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 149
Effectiveness of an Adapted Physical Activity Protocol for Upper Extremity Recovery and Quality of Life Improvement in a Case of Seroma after Breast Cancer Treatment 149
Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α. 148
Occult spondyloarthritis in inflammatory bowel disease 148
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 148
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 146
Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction 146
Adapted Physical Activity Protocol for Lower Limb Functional and Strength Recovery in a Young Athlete with Cutaneous Melanoma: Feasibility and Efficacy during COVID-19 Pandemic 145
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 145
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 145
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 144
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 144
Changes in the telocyte/CD34+ stromal cell and α-SMA+ myoid cell networks in human testicular seminoma 144
Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis 144
Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis 144
Physical activity and sport practice to improve balance control of visually impaired individuals: a narrative review with future perspectives 143
Morphological evidence of telocytes in human synovium 143
Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva 143
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 143
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 142
Tailored sailing experience to reduce psychological distress and improve the quality of life of breast cancer survivors: A survey-based pilot study 142
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 141
Telocytes in Crohn's disease 141
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 140
Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? 140
Characterization and distribution of sialic acids in human testicular seminoma 140
Adapted Training to Boost Upper Body Sensorimotor Control and Daily Living Functionality in Visually Impaired Baseball Players 139
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis 139
Variations of neuronal nitric oxide synthase in systemic sclerosis skin 139
Reactive agility and pitching performance improvement in visually impaired competitive Italian baseball players: an innovative training and evaluation proposal 137
The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes 137
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells 137
Fli1 deficiency and beyond: a unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis 137
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 137
Biofeedback-Based Proprioceptive Training to Improve Functional Prerequisites of Dragon Boating in Breast Cancer Survivors 136
STIMULATION OF SOLUBLE GUANYLATE CYCLASE (sGC) FOSTERS ANGIOGENESIS AND BLUNTS ENDOTHELIAL-TO-MESENCHYMAL TRANSITION (EndoMT) OF SYSTEMIC SCLEROSIS (SSc) DERMAL MICROVASCULAR ENDOTHELIAL CELLS 136
Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis 135
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 134
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 134
Adapted physical activity protocol for the management of breast cancer-related upper limb lymphedema 133
Totale 16.984
Categoria #
all - tutte 89.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.477 0 0 0 0 0 211 149 155 287 382 152 141
2021/20221.363 30 84 72 71 57 112 51 64 101 83 144 494
2022/20233.474 374 641 149 245 231 637 489 187 325 48 84 64
2023/20241.460 43 174 281 72 104 198 84 233 22 78 98 73
2024/202510.189 380 1.072 701 1.486 2.962 1.051 334 587 462 321 369 464
2025/20267.265 1.301 1.676 1.374 1.467 1.418 29 0 0 0 0 0 0
Totale 31.760